High clustering rate and genotypic drug-susceptibility screening for the newly recommended anti-tuberculosis drugs among global extensively drug-resistant <i>Mycobacterium tuberculosis</i> isolates-Reference-Cited by-同舟云学术

High clustering rate and genotypic drug-susceptibility screening for the newly recommended anti-tuberculosis drugs among global extensively drug-resistant Mycobacterium tuberculosis isolates

Published:2022-07-27 Issue:1 Volume:11 Page:1857-1866
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Trisakul Kanwara¹²^ORCID,Nonghanphithak Ditthawat¹²^ORCID,Chaiyachat Pratchakan¹²^ORCID,Kaewprasert Orawee¹²^ORCID,Sakmongkoljit Kankanon³^ORCID,Reechaipichitkul Wipa¹²^ORCID,Chaiprasert Angkana⁴^ORCID,Blair David⁵^ORCID,Clark Taane G.⁶^ORCID,Faksri Kiatichai¹²^ORCID

Affiliation:

1. Department of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand

2. Research and Diagnostic Center for Emerging Infectious Diseases (RCEID), Khon Kaen University, Khon Kaen, Thailand

3. Department of Geotechnology, Faculty of Technology, Khon Kaen University, Khon Kaen, Thailand

4. Office for Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

5. James Cook University, Townsville, Australia

6. London School of Hygiene and Tropical Medicine, London, UK

Funder

National Research Council of Thailand

NSTDA Thailand

Medical Research Council UK

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2022.2099304

Reference43 articles.

1. World Health Organization. Global tuberculosis report 2021; [cited 16 December 2021]. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2021.

2. WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment. [cited 28 December 2021]. Available from: https://www.who.int/publications-detail-redirect/9789240007048.

3. Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis; [cited 10 February 2022]. Available from: https://www.who.int/publications-detail-redirect/meeting-report-of-the-who-expert-consultation-on-the-definition-of-extensively-drug-resistant-tuberculosis.

4. Whole-genome analysis of drug-resistant Mycobacterium tuberculosis reveals novel mutations associated with fluoroquinolone resistance

5. The relationship between transmission time and clustering methods in Mycobacterium tuberculosis epidemiology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms of resistance and treatment efficacy of clofazimine and bedaquiline against Mycobacterium tuberculosis;Frontiers in Medicine;2024-01-10

2. Drug resistance prediction for Mycobacterium tuberculosis with reference graphs;Microbial Genomics;2023-08-08

3. Metabolomic analysis of Mycobacterium tuberculosis reveals metabolic profiles for identification of drug-resistant tuberculosis;Scientific Reports;2023-05-27

4. Drug resistance prediction forMycobacterium tuberculosiswith reference graphs;2023-05-04

5. Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement;The Lancet Infectious Diseases;2023-04